Biosensors Market
The market for Biosensors was estimated at $26.5 billion in 2024; it is anticipated to increase to $47.5 billion by 2030, with projections indicating growth to around $77.1 billion by 2035.
Global Biosensors Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Biosensors industry revenue is expected to be around $29.2 billion in 2025 and expected to showcase growth with 10.2% CAGR between 2025 and 2034.
Biological sensors are tools that combine an element with a physical and chemical detector to show the existence of different biomaterials at a molecular level in a visual way. They are specific and efficient devices that offer quick results at low costs. These sensors play roles in industries such as biotechnology and agriculture testing as well, as ensuring food safety and aiding in medical diagnoses.
Market Key Insights
- The Biosensors market is projected to grow from $26.5 billion in 2024 to $70.0 billion in 2034. This represents a CAGR of 10.2%, reflecting rising demand across Medical Diagnostics, Food and Beverage Industry and Environmental Monitoring.
- Abbott Laboratories, F. Hoffmann-La Roche Ltd, Medtronic are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Biosensors market and are expected to observe the growth CAGR of 7.4% to 10.7% between 2024 and 2030.
- Emerging markets including India, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 9.8% to 12.8%.
- Transition like Emergence of Wearable Technology is expected to add $2 billion to the Biosensors market growth by 2030.
- The Biosensors market is set to add $43.5 billion between 2024 and 2034, with manufacturer targeting Optical & Thermal Technology projected to gain a larger market share.
- With Increasing healthcare expenditure, and Technological advancements in biosensors, Biosensors market to expand 164% between 2024 and 2034.